Eric Lefebvre, Chief Medical Officer at PLIANT THERAPEUTICS, INC. (PLRX), sold 67,500 shares at $34.48 ($2.3M) on 2023-01-23, disclosed to the SEC on 2023-01-25.
Open-market sale of $2.3M PLRX by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| PLRX | SELL | 2024-01-19 | $355K | — | Filing → |
| PLRX | SELL | 2023-07-19 | $804K | — | Filing → |
| PLRX | SELL | 2023-04-03 | $596K | — | Filing → |